What is the newest ADHD medication? An overview of recent treatment developments
•
4 min read
In May 2024, the U.S. Food and Drug Administration (FDA) approved Onyda XR, a liquid non-stimulant, for pediatric ADHD, making it one of the newest ADHD medication options available. This approval, alongside other emerging drugs in clinical trials, highlights the ongoing advancements in pharmacology aimed at expanding treatment choices.
